🇺🇸 FDA
Patent

US 8877765

Highly soluble pyrimido-dione-quinoline compounds and their use in the treatment of cancer

granted A61KA61K31/519A61P

Quick answer

US patent 8877765 (Highly soluble pyrimido-dione-quinoline compounds and their use in the treatment of cancer) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/519, A61P, A61P35/00